Ilumya® (tildrakizumab-asmn) approved in the U.S. for the Treatment of Adults with Active Psoriatic Arthritis PR Newswire (Press Release) 13h
Sun Pharma shares rise 2%; gets US FDA approval for Ilumya to treat psoriatic arthritis The Financial Express 17h
Khawaja reveals secret battle with rheumatoid arthritis The Independent 5d Usman Khawaja Australia Cricket Team Cricket Article paywall All sources
Sun Pharma shares rise 2%; gets US FDA approval for ILUMYA to treat psoriatic arthritis The Financial Express 17h ILUMYA FDA Pharma
Robot Arthur in UK-first for hand arthritis scans BBC 12:14 Wed, 21 Oct UK Health Technology (UK) Global Health All sources
Patient-Reported outcomes worse for patients with RA discontinuing TNF inhibitor Clinical Pain Advisor 2d
FDA plans to make rare disease Drug review faster and more efficient JD Supra 1d HHS Rare Diseases Pharma All sources
Butter recalled over yeast, mold and E.coli concerns gets FDA risk classification ABC News 2d All sources
FDA issues alert about beds sold by Medline after deaths, injuries Daily Breeze 26m Medline All sources
Sun Pharma shares rise 2%; gets US FDA approval for ILUMYA to treat psoriatic arthritis The Financial Express 17h ILUMYA Arthritis Pharma
